GUMC Update - The online newsletter of the Georgetown University Medical Center Community
More online news >

The trial is the first to compare standard of care chemotherapy with molecularly tailored therapy (also known as precision medicine) for metastatic pancreatic cancer. 
Read More >

In 2013, triathlete Shannon Semple was diagnosed with stage four thymic carcinoma. After participating in an immunotherapy study, she has no detectable disease. 

Kara-Grace Leventhal forged a connection to the Georgetown medical community years prior to being admitted to the 2018 School of Medicine class.


Jack Shonkoff, MD,  was awarded GUMC's  "Caring for Children Lifetime Achievement Award" for his focus on early childhood brain development.     

  • GUMC Engagement Survey - Please Complete by Friday, July 22
    Dr. Ed Healton invites you to participate in a deeper discussion of the five priority areas identified for the Medical Center through the engagement process. Read more and take a brief survey here
  • Key Leadership Changes at the School of Medicine 
    Dean Ray Mitchell announced new leaders in the Office of medical education. Read more here
  • Request for Applications 
    Georgetown-Howard Universities Center for Clinical and Translational Science is now accepting applications for its KL2 Junior Faculty Scholars program. Applications are due August 19. 
  • Parkinson's Fellowship Opportunity
    Application deadlines approaching for the Georgetown University and The Michael J. Fox Foundation fellowship in regulatory science for Parkinson's disease research at Georgetown. 
  • Orphan Drug Designation Based on Lombardi Work
    TK216, an agent being developed by Georgetown and Oncternal, received
    Orphan Drug Designation from the FDA. TK216 is in clinical trials for the treatment of Ewing sarcoma. The drug is based on original work from Jeffrey A. Toretsky's lab. He is named as inventor of the underlying technology and related intellectual property owned by Georgetown.
  • CERSI Scholars Announced
    The Georgetown University Center of Excellence in Regulatory Science and Innovation (CERSI) has named its 2016-2017 CERSI Scholars. Ten research stipends were awarded to early career investigators from Georgetown and MedStar Health "who are deeply committed to public health and actively pursuing research, education, or training in regulatory science." The CERSI Scholars program is co-sponsored by the Georgetown University Medical Center and MedStar Health Research Institute. Meet the new scholars.

Public Health Benefits of E-cigarette Use Tend to Outweigh the Harms
WASHINGTON  (July 14, 2016) - A modeling study by top tobacco control experts finds that e-cigarettes are likely to provide public health benefits based on "conservative estimates" of the likely uptake of vaping and smoking by adolescents and young adults.
Read More >

WASHINGTON (July 13, 2016) - Eleven years ago in the New England Journal of Medicine, medical journalist Susan Okie, MD, first introduced readers to two U.S. Army veterans who suffered traumatic brain injuries in Iraq, and the challenges they faced in the recovery period after returning home. In the July 14 issue of the NEJM, Okie describes her follow-up interviews with the soldiers, and the slow journey to recovery that continues more than a decade later.
WASHINGTON (July 11, 2016) - A small phase I study provides molecular evidence that an FDA-approved drug for leukemia significantly increased brain dopamine and reduced toxic proteins linked to disease progression in patients with Parkinson's disease or dementia with Lewy bodies.


Bloomberg E-Cigarettes May Help More Than They Hurt with David Levy, July 14, 2016
Drug Discovery & Development Cancer Drug Could Improve Parkinson's Symptoms  with Charlie Moussa, July 14, 2016
US News & World Report (HealthDay) Cancer Drug Shows Early Promise for Parkinson's Disease with Charlie Moussa, July 12, 2016
BioPharma Dive Cancer drug could benefit Parkinson's patients, study shows with Charlie Moussa, July 11, 2016
BBC Radioactivity: Friend or Foe? With Timothy Jorgensen, July 11, 2016
WTOP CDC report: HPV-related cancers are on the rise with Ranit Mishori, July 7, 2016
The Washington Post Leading researchers recommend major change in prostate cancer treatment with Nancy Dawson, July 6, 2016
The Washington Post  Pfizer agrees to truth in opioid marketing with Adriane Fugh-Berman, July 5, 2016
But wait, there's more! Read about other GUMC faculty "In The News" here.


Resources and policy changes needed to reduce infections and improve health outcomes remain sluggish to meet the needs of this public health crisis. 
More events >

Friday, July 22
12:00 p.m.
Virtual Session, Webinar 
GI Cancer Patient Summit
Saturday, July 23 
9:00 a.m. - 2:30 p.m. 
The Conference Center at FASEB 
9650 Rockville Pike, Bethesda, MD 
To register email

Save the Dates! 

SOM White Coat Ceremony 
Friday, August 5 
3:30 p.m
Gaston Hall  

BGE Student Research Day
Tuesday, September 27 
All day event 

To view previous issues of GUMC Update, visit the Update Archive.

Copyright Georgetown University 2014
About the Update | | Contact Us